New monthly shot could transform opioid addiction care in developing nations
NCT ID NCT06129916
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a monthly injection of buprenorphine (a medication for opioid dependence) works well and is affordable in low- and middle-income countries. About 760 adults who inject drugs and have opioid dependence will receive the injection and be followed for 48 weeks. The goal is to see if this long-acting option improves treatment satisfaction, keeps people in care, and reduces opioid use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID DEPENDENCE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple helpline help fight opioid addiction?
- Zapping the brain to beat opioid relapse: new study tests Non-Invasive technique
- New parenting program aims to strengthen bonds for moms battling opioid addiction
- New hope for pain relief without addiction: buprenorphine study
- New program aims to help surgery patients safely wean off opioids
- Old gout drug could help people taper off opioids